HIVE vs SIDU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

HIVE

48.2
AI Score
VS
HIVE Wins

SIDU

38.0
AI Score

Investment Advisor Scores

HIVE

48score
Recommendation
HOLD

SIDU

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIVE SIDU Winner
Revenue 79.12M 942,468 HIVE
Net Income -142.91M -9.99M SIDU
Gross Margin -37.3% -178.2% HIVE
Net Margin -180.6% -1060.3% HIVE
ROE -33.8% -5.3% SIDU
ROA -15.5% -5.1% SIDU
Total Assets 924.64M 194.80M HIVE
Cash 208.04M 166.52M HIVE
Current Ratio 1.96 33.29 SIDU

Relative Price Performance (Last 90 Days)

HIVE 1M: -4.7% · 3M: -21.3% SIDU 1M: +20.3% · 3M: -42.6%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

SIDU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.3 · Price: $2.37

Fundamentals Snapshot

Metric HIVE SIDU
Market Cap
Forward P/E -5.9 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.7% -0.5%
Gross Margin 0.4% -1.7%
Operating Margin -0.6% -9.8%
EPS -1.54 -0.66
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.